-
1دورية أكاديمية
المؤلفون: Inna Serganova, Ekaterina Moroz, Ivan Cohen, Maxim Moroz, Mayuresh Mane, Juan Zurita, Larissa Shenker, Vladimir Ponomarev, Ronald Blasberg
المصدر: Molecular Therapy: Oncolytics, Vol 4, Iss C, Pp 41-54 (2017)
مصطلحات موضوعية: prostate cancer, human PSMA, CAR T cells, anti-PD1, bioluminescence imaging, BLI, luciferase reporters, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Mayuresh Mane, Vladimir Ponomarev, Inna Serganova, Juan Zurita, Larissa Shenker, Ivan Cohen, Maxim A. Moroz, Ekaterina Moroz, Ronald G. Blasberg
المصدر: Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 4, Iss C, Pp 41-54 (2017)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.drug_class, CD3, medicine.medical_treatment, Monoclonal antibody, lcsh:RC254-282, CAR T cells, 03 medical and health sciences, 0302 clinical medicine, Immune system, PD-L1, medicine, Bioluminescence imaging, Pharmacology (medical), anti-PD1, luciferase reporters, human PSMA, biology, bioluminescence imaging, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, prostate cancer, Chimeric antigen receptor, 3. Good health, Blockade, BLI, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Immunology, biology.protein, Molecular Medicine, Original Article
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Serganova I; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Moroz E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Cohen I; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, NY 10065, USA., Moroz M; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Mane M; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Zurita J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Shenker L; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ponomarev V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Blasberg R; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
المصدر: Molecular therapy oncolytics [Mol Ther Oncolytics] 2016 Dec 14; Vol. 4, pp. 41-54. Date of Electronic Publication: 2016 Dec 14 (Print Publication: 2017).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE